Stem Cell Market Research Reports

"...... ct, the Europe stem cell market is anticipated to register a CAGR of 9.24% by the end of the forecast period of 2019-2027. MARKET INSIGHTS Several European markets analyzed in this region include UK, Germany, France, Spain, Ital......"

"...... tors driving the stem cell market. MARKET INSIGHTS Stem cell market is segmented by products, treatment type, technology, therapeutic application, and applications. The United States and Canada are the two key countries in the ......"

"...... ding lifespan are contributing to the market growth for stem cell. MARKET INSIGHTS The global stem cell market is segmented on the basis of product, technology, application therapeutic, application, and treatment type, and geog......"

"...... to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression. Scope of the Report: The global Autologous Cell Therapy market is valued at xx million USD in 2018......"

"...... cells—specifically, the destruction of preimplantation human embryos. Despite differences in public opinion on this issue, a large majority of the public supports continued research using embryonic stem cells. Maintenance of......"

"...... ll therapy candidate under development by one of the key companies Neuralstem. The molecule is being developed for the treatment of individuals with diabetic neuropathy and is currently in the pre-clinical development stage. The mechanism of action o......"

"...... modified to behave like pluripotent stem cells or embryonic stem cells. iPSCs market is in emerging state mainly due to its ability to make any cell or tissue the body might need to encounter wide range of diseases like diabetes, spinal cord ......"

"...... are wide; the most frequent indication as per reported by Worldwide Network for Blood and Marrow Transplantation Group (WNBT) (2013) is lymphoproliferative disorder (53.2% of all HSCT), 12% of whom received allogeneic and the rest received autologou......"

"...... is because of increasing awareness of osteoarthritis and increasing diagnosis rates, rising older population, and increasing cases of obesity. Osteoarthritis is directly related to obesity, with approximately 35% of osteoarthritis patients suffering......"

"...... future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell Assay development in United States, Europe and China. The key players covered in this study - Merck - Ther......"